Pharma 4.0 시장 성장 및 동향 분석 보고서

조사회사 : Grand View Research  출판년월 : 2024년07월

Pharma 4.0 Market Size, Share & Trends Analysis Report

Pharma 4.0 시장 : 유형(소프트웨어, 서비스), 기술(AI/ML, 빅데이터 분석, IoT, 블록체인 기술), 애플리케이션, 최종 사용, 지역별 및 세그먼트 예측을 통한 시장 규모, 성장 및 동향 분석 보고서 2024-2030년
Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software, Services), By Technology (AI/ML, Big Data Analytics, IoT, Blockchain Technology), By Application, By End-use, By Region, And Segment Forecasts, 2024 – 2030

　　　　주문/문의　　　　조사회사/라이센스/납기안내

Pharma 4.0 Market Growth & Trends

The global pharma 4.0 market size is expected to reach USD 35.79 billion by 2030, registering a CAGR of 18.96% from 2024 to 2030, according to a new report by Grand View Research, Inc.

세계 Pharma 4.0(제약 4.0) 시장 규모는 2030년까지 357억 9,000만 달러에 달할 것으로 예상되며, 2024년부터 2030년에 걸쳐 18.96%의 CAGR을 기록합니다.

The pharma 4.0 market is being driven by several key factors, including the rising demand for personalized medicine, the need for improved efficiency and cost reduction, supply chain optimization, and an increasing focus on patient-centric approaches. The growing prevalence of chronic disorders and rare diseases has heightened the demand for personalized medicine. Pharma 4.0 technologies, such as additive manufacturing (3D printing) and modular production facilities, enable the production of personalized medicines and small batches tailored to individual patient needs, supporting this trend.

In addition, increasing adoption of digital technologies is driving the market growth. These technologies optimize, improve, and revolutionize drug development, manufacturing, distribution, and patient care. Blockchain technology has significantly reshaped supply chain management by offering transparency, traceability, and optimization, reducing stockouts, preventing counterfeiting, and enhancing overall efficiency and patient safety.

Pharma 4.0 Market Report Scope

Furthermore, the market growth is being driven by increasing investments from pharmaceutical companies in adopting Pharma 4.0 technologies. For example, AstraZeneca signed a deal worth up to USD 840 million for the target identification of rare neurodegenerative and neuromuscular diseases. As part of this deal, AstraZeneca’s Alexion division will collaborate with Verge Genomics to identify drug targets for these conditions. Over the course of the four-year, multi-target agreement, the companies will utilize machine learning to analyze Verge’s genomic datasets, which are derived from human tissue rather than cell or animal models.

Pharma 4. 0 Market Report Highlights

• On the basis of type, the software segment dominated the market in 2023, owing to the increasing adoption of software due to various benefits such as efficiency enhancement, improved compliance and productivity. In addition, the IoT enabled software help in real time monitoring and tracking of manufacturing process, leading to better process control and reduces the downtime

• On the basis of technology, the AI & ML segment held the largest market share owing to growing adoption of AI and increasing investments. For instance, as per a survey, over 75% of pharma executives plan to apply AI to speed drug discovery by 2025

• On the basis of application, the drug discovery & development dominated the market in 2023 due to increased investment in AI for drug discovery startups

• Pharma & biotech segment held the largest market share of 49.8% in 2023. Pharmaceutical companies are increasingly adopting Pharma 4.0 technologies to enhance efficiency, productivity, and quality in their manufacturing processes thereby driving the segment growth

• North America dominated the global market with a revenue share of 41.12% in 2023. The growth is attributed to the increasing government initiative, technological advancement in the healthcare industry, and a strong presence of key market players

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.1.1. Type

1.1.2. Technology

1.1.3. Application

1.1.4. End Use

1.1.5. Regional scope

1.1.6. Estimates and forecast timeline.

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased database.

1.3.2. GVR’s internal database

1.3.3. Secondary sources

1.3.4. Primary research

1.3.5. Details of primary research

1.4. Information or Data Analysis

1.4.1. Data analysis models

1.5. Market Formulation & Validation

1.6. Model Details

1.6.1. Commodity flow analysis (Model 1)

1.6.2. Approach 1: Commodity flow approach

1.6.3. Volume price analysis (Model 2)

1.6.4. Approach 2: Volume price analysis

1.7. List of Secondary Sources

1.8. List of Primary Sources

1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. Pharma 4.0 Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.2. Market restraint analysis

3.3. Pharma 4.0 Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Supplier power

3.3.1.2. Buyer power

3.3.1.3. Substitution threat

3.3.1.4. Threat of new entrant

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Technological landscape

3.3.2.3. Economic landscape

3.3.3. COVID-19 Impact

Chapter 4. Pharma 4.0 Market: Type Estimates & Trend Analysis

4.1. Type Market Share, 2023 & 2030

4.2. Segment Dashboard

4.3. Global Pharma 4.0 Market by Type Outlook

4.4. Software

4.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)

4.5. Services

4.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Pharma 4.0 Market: Technology Estimates & Trend Analysis

5.1. Technology Market Share, 2023 & 2030

5.2. Segment Dashboard

5.3. Global Pharma 4.0 Market by Technology Outlook

5.4. AI & ML

5.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)

5.5. Big Data Analytics

5.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)

5.6. IoT

5.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)

5.7. Block chain Technology

5.7.1. Market estimates and forecast 2018 to 2030 (USD Billion)

5.8. Others (Digital twin, Advanced robotics, AR &VR)

5.8.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Pharma 4.0 Market: Application Estimates & Trend Analysis

6.1. Application Market Share, 2023 & 2030

6.2. Segment Dashboard

6.3. Global Pharma 4.0 Market by Application Outlook

6.4. Drug Discovery & Development

6.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)

6.5. Manufacturing

6.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)

6.6. Supply Chain Management

6.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)

6.7. Others (Product Lifecycle Management, Personalized Medicine, Regulatory Compliance)

6.7.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Pharma 4.0 Market: End Use Estimates & Trend Analysis

7.1. End Use Market Share, 2023 & 2030

7.2. Segment Dashboard

7.3. Global Pharma 4.0 Market by End Use Outlook

7.4. Pharma & Biotech companies

7.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)

7.5. Healthcare Providers

7.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)

7.6. CRO & CDMO

7.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 8. Pharma 4.0 Market: Regional Estimates & Trend Analysis, By type, By technology, By Application, By End Use

8.1. Regional Market Share Analysis, 2023 & 2030

8.2. Regional Market Dashboard

8.3. Global Regional Market Snapshot

8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030

8.5. North America

8.5.1. U.S.

8.5.1.1. Key country dynamics

8.5.1.2. Regulatory framework/ reimbursement structure

8.5.1.3. Competitive scenario

8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)

8.5.2. Canada

8.5.2.1. Key country dynamics

8.5.2.2. Regulatory framework/ reimbursement structure

8.5.2.3. Competitive scenario

8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)

8.5.3. Mexico

8.5.3.1. Key country dynamics

8.5.3.2. Regulatory framework/ reimbursement structure

8.5.3.3. Competitive scenario

8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)

8.6. Europe

8.6.1. UK

8.6.1.1. Key country dynamics

8.6.1.2. Regulatory framework/ reimbursement structure

8.6.1.3. Competitive scenario

8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)

8.6.2. Germany

8.6.2.1. Key country dynamics

8.6.2.2. Regulatory framework/ reimbursement structure

8.6.2.3. Competitive scenario

8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)

8.6.3. France

8.6.3.1. Key country dynamics

8.6.3.2. Regulatory framework/ reimbursement structure

8.6.3.3. Competitive scenario

8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)

8.6.4. Italy

8.6.4.1. Key country dynamics

8.6.4.2. Regulatory framework/ reimbursement structure

8.6.4.3. Competitive scenario

8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)

8.6.5. Spain

8.6.5.1. Key country dynamics

8.6.5.2. Regulatory framework/ reimbursement structure

8.6.5.3. Competitive scenario

8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)

8.6.6. Norway

8.6.6.1. Key country dynamics

8.6.6.2. Regulatory framework/ reimbursement structure

8.6.6.3. Competitive scenario

8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)

8.6.7. Sweden

8.6.7.1. Key country dynamics

8.6.7.2. Regulatory framework/ reimbursement structure

8.6.7.3. Competitive scenario

8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)

8.6.8. Denmark

8.6.8.1. Key country dynamics

8.6.8.2. Regulatory framework/ reimbursement structure

8.6.8.3. Competitive scenario

8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)

8.7. Asia Pacific

8.7.1. Japan

8.7.1.1. Key country dynamics

8.7.1.2. Regulatory framework/ reimbursement structure

8.7.1.3. Competitive scenario

8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)

8.7.2. China

8.7.2.1. Key country dynamics

8.7.2.2. Regulatory framework/ reimbursement structure

8.7.2.3. Competitive scenario

8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)

8.7.3. India

8.7.3.1. Key country dynamics

8.7.3.2. Regulatory framework/ reimbursement structure

8.7.3.3. Competitive scenario

8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)

8.7.4. Australia

8.7.4.1. Key country dynamics

8.7.4.2. Regulatory framework/ reimbursement structure

8.7.4.3. Competitive scenario

8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)

8.7.5. South Korea

8.7.5.1. Key country dynamics

8.7.5.2. Regulatory framework/ reimbursement structure

8.7.5.3. Competitive scenario

8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)

8.7.6. Thailand

8.7.6.1. Key country dynamics

8.7.6.2. Regulatory framework/ reimbursement structure

8.7.6.3. Competitive scenario

8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)

8.8. Latin America

8.8.1. Brazil

8.8.1.1. Key country dynamics

8.8.1.2. Regulatory framework/ reimbursement structure

8.8.1.3. Competitive scenario

8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)

8.8.2. Argentina

8.8.2.1. Key country dynamics

8.8.2.2. Regulatory framework/ reimbursement structure

8.8.2.3. Competitive scenario

8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)

8.9. MEA

8.9.1. South Africa

8.9.1.1. Key country dynamics

8.9.1.2. Regulatory framework/ reimbursement structure

8.9.1.3. Competitive scenario

8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)

8.9.2. Saudi Arabia

8.9.2.1. Key country dynamics

8.9.2.2. Regulatory framework/ reimbursement structure

8.9.2.3. Competitive scenario

8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)

8.9.3. UAE

8.9.3.1. Key country dynamics

8.9.3.2. Regulatory framework/ reimbursement structure

8.9.3.3. Competitive scenario

8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)

8.9.4. Kuwait

8.9.4.1. Key country dynamics

8.9.4.2. Regulatory framework/ reimbursement structure

8.9.4.3. Competitive scenario

8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants

9.2. Company/Competition Categorization

9.3. Key company market share analysis, 2023

9.4. Company Profiles

9.4.1. Microsoft Corporation

9.4.1.1. Company overview

9.4.1.2. Financial performance

9.4.1.3. Product benchmarking

9.4.1.4. Strategic initiatives

9.4.2. IBM

9.4.2.1. Company overview

9.4.2.2. Financial performance

9.4.2.3. Product benchmarking

9.4.2.4. Strategic initiatives

9.4.3. Amazon Web Service (AWS)

9.4.3.1. Company overview

9.4.3.2. Financial performance

9.4.3.3. Product benchmarking

9.4.3.4. Strategic initiatives

9.4.4. SAP

9.4.4.1. Company overview

9.4.4.2. Financial performance

9.4.4.3. Product benchmarking

9.4.4.4. Strategic initiatives

9.4.5. Oracle

9.4.5.1. Company overview

9.4.5.2. Financial performance

9.4.5.3. Product benchmarking

9.4.5.4. Strategic initiatives

9.4.6. GE Healthcare

9.4.6.1. Company overview

9.4.6.2. Financial performance

9.4.6.3. Product benchmarking

9.4.6.4. Strategic initiatives

9.4.7. Siemens Healthineers

9.4.7.1. Company overview

9.4.7.2. Financial performance

9.4.7.3. Product benchmarking

9.4.7.4. Strategic initiatives

9.4.8. Cisco

9.4.8.1. Company overview

9.4.8.2. Financial performance

9.4.8.3. Product benchmarking

9.4.8.4. Strategic initiatives

9.4.9. Cinntra

9.4.9.1. Company overview

9.4.9.2. Financial performance

9.4.9.3. Product benchmarking

9.4.9.4. Strategic initiatives

9.4.10. Dassault Systems

9.4.10.1. Company overview

9.4.10.2. Financial performance

9.4.10.3. Product benchmarking

9.4.10.4. Strategic initiatives

9.4.11. Nexocode

9.4.11.1. Company overview

9.4.11.2. Financial performance

9.4.11.3. Product benchmarking

9.4.11.4. Strategic initiatives

List of Tables

List of Tables

Table 1 List of abbreviation

Table 2 North America Pharma 4.0 Market, by region, 2018 – 2030 (USD Million)

Table 3 North America Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 4 North America Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 5 North America Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 6 North America Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 7 U.S. Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 8 U.S. Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 9 U.S. Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 10 U.S. Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 11 Canada Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 12 Canada Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 13 Canada Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 14 Canada Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 15 Mexico Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 16 Mexico Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 17 Mexico Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 18 Mexico Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 19 Europe Pharma 4.0 Market, by region, 2018 – 2030 (USD Million)

Table 20 Europe Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 21 Europe Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 22 Europe Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 23 Europe Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 24 Germany Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 25 Germany Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 26 Germany Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 27 Germany Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 28 UK Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 29 UK Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 30 UK Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 31 UK Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 32 France Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 33 France Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 34 France Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 35 France Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 36 Italy Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 37 Italy Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 38 Italy Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 39 Italy Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 40 Spain Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 41 Spain Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 42 Spain Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 43 Spain Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 44 Denmark Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 45 Denmark Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 46 Denmark Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 47 Denmark Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 48 Sweden Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 49 Sweden Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 50 Sweden Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 51 Sweden Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 52 Norway Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 53 Norway Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 54 Norway Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 55 Norway Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 56 Asia Pacific Pharma 4.0 Market, by region, 2018 – 2030 (USD Million)

Table 57 Asia Pacific Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 58 Asia Pacific Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 59 Asia Pacific Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 60 Asia Pacific Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 61 China Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 62 China Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 63 China Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 64 China Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 65 Japan Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 66 Japan Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 67 Japan Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 68 Japan Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 69 India Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 70 India Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 71 India Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 72 India Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 73 South Korea Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 74 South Korea Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 75 South Korea Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 76 South Korea Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 77 Australia Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 78 Australia Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 79 Australia Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 80 Australia Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 81 Thailand Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 82 Thailand Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 83 Thailand Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 84 Thailand Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 85 Latin America Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 86 Latin America Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 87 Latin America Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 88 Latin America Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 89 Brazil Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 90 Brazil Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 91 Brazil Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 92 Brazil Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 93 Argentina Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 94 Argentina Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 95 Argentina Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 96 Argentina Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 97 MEA Pharma 4.0 Market, by region, 2018 – 2030 (USD Million)

Table 98 MEA Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 99 MEA Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 100 MEA Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 101 MEA Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 102 South Africa Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 103 South Africa Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 104 South Africa Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 105 South Africa Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 106 Saudi Arabia Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 107 Saudi Arabia Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 108 Saudi Arabia Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 109 Saudi Arabia Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 110 UAE Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 111 UAE Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 112 UAE Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 113 UAE Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

Table 114 Kuwait Pharma 4.0 Market, by type, 2018 – 2030 (USD Million)

Table 115 Kuwait Pharma 4.0 Market, by technology, 2018 – 2030 (USD Million)

Table 116 Kuwait Pharma 4.0 Market, by application, 2018 – 2030 (USD Million)

Table 117 Kuwait Pharma 4.0 Market, by end use, 2018 – 2030 (USD Million)

List of Figures

List of Figures

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Pharma 4.0 Market: market outlook

Fig. 9 Cryostat competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 Pharma 4.0 Market driver impact

Fig. 15 Pharma 4.0 Market restraint impact

Fig. 16 Pharma 4.0 Market strategic initiatives analysis

Fig. 17 Pharma 4.0 Market: Type movement analysis

Fig. 18 Pharma 4.0 Market: Type outlook and key takeaways

Fig. 19 Software market estimates and forecast, 2018 – 2030

Fig. 20 Services market estimates and forecast, 2018 – 2030

Fig. 21 Pharma 4.0 Market: Technology movement analysis

Fig. 22 Pharma 4.0 Market: Technology outlook and key takeaways

Fig. 23 AI & ML market estimates and forecast, 2018 – 2030

Fig. 24 Big data analytics market estimates and forecast, 2018 – 2030

Fig. 25 IoT market estimates and forecast, 2018 – 2030

Fig. 26 Block chain technology market estimates and forecast, 2018 – 2030

Fig. 27 Others market estimates and forecast, 2018 – 2030

Fig. 28 Pharma 4.0 Market: Application movement analysis

Fig. 29 Pharma 4.0 Market: Application outlook and key takeaways

Fig. 30 Drug Discovery & Development market estimates and forecast, 2018 – 2030

Fig. 31 Manufacturing market estimates and forecast, 2018 – 2030

Fig. 32 Supply Chain Management market estimates and forecast, 2018 – 2030

Fig. 33 Others market estimates and forecast, 2018 – 2030

Fig. 34 Pharma 4.0 Market: End Use movement analysis

Fig. 35 Pharma 4.0 Market: End Use outlook and key takeaways

Fig. 36 Pharma & Biotech companies market estimates and forecast, 2018 – 2030

Fig. 37 Healthcare providers market estimates and forecast, 2018 – 2030

Fig. 38 CRO & CDMO market estimates and forecast, 2018 – 2030

Fig. 39 Global Pharma 4.0 Market: Regional movement analysis

Fig. 40 Global Pharma 4.0 Market: Regional outlook and key takeaways

Fig. 41 Global Pharma 4.0 Market share and leading players

Fig. 42 North America market share and leading players

Fig. 43 Europe market share and leading players

Fig. 44 Asia Pacific market share and leading players

Fig. 45 Latin America market share and leading players

Fig. 46 Middle East & Africa market share and leading players

Fig. 47 North America: SWOT

Fig. 48 Europe SWOT

Fig. 49 Asia Pacific SWOT

Fig. 50 Latin America SWOT

Fig. 51 MEA SWOT

Fig. 52 North America, by country

Fig. 53 North America market estimates and forecasts, 2018 – 2030

Fig. 54 U.S. market estimates and forecasts, 2018 – 2030

Fig. 55 Canada market estimates and forecasts, 2018 – 2030

Fig. 56 Mexico market estimates and forecasts, 2018 – 2030

Fig. 57 Europe market estimates and forecasts, 2018 – 2030

Fig. 58 UK market estimates and forecasts, 2018 – 2030

Fig. 59 Germany market estimates and forecasts, 2018 – 2030

Fig. 60 France market estimates and forecasts, 2018 – 2030

Fig. 61 Italy market estimates and forecasts, 2018 – 2030

Fig. 62 Spain market estimates and forecasts, 2018 – 2030

Fig. 63 Denmark market estimates and forecasts, 2018 – 2030

Fig. 64 Sweden market estimates and forecasts, 2018 – 2030

Fig. 65 Norway market estimates and forecasts, 2018 – 2030

Fig. 66 Asia Pacific market estimates and forecasts, 2018 – 2030

Fig. 67 China market estimates and forecasts, 2018 – 2030

Fig. 68 Japan market estimates and forecasts, 2018 – 2030

Fig. 69 India market estimates and forecasts, 2018 – 2030

Fig. 70 South Korea market estimates and forecasts, 2018 – 2030

Fig. 71 Australia market estimates and forecasts, 2018 – 2030

Fig. 72 Thailand market estimates and forecasts, 2018 – 2030

Fig. 73 Latin America market estimates and forecasts, 2018 – 2030

Fig. 74 Brazil market estimates and forecasts, 2018 – 2030

Fig. 75 Argentina market estimates and forecasts, 2018 – 2030

Fig. 76 Middle East and Africa market estimates and forecasts, 2018 – 2030

Fig. 77 South Africa market estimates and forecasts, 2018 – 2030

Fig. 78 Saudi Arabia market estimates and forecasts, 2018 – 2030

Fig. 79 UAE market estimates and forecasts, 2018 – 2030

Fig. 80 Kuwait market estimates and forecasts, 2018 – 2030

Fig. 81 Market share of key market players- Pharma 4.0 Market